<DOC>
	<DOC>NCT00753779</DOC>
	<brief_summary>The primary objective is to determine the effect of WelChol tablets on serum lipids, lipoproteins, apolipoproteins, and lipoprotein particle size in patients who were stabilized on simvastatin therapy for at least 4 weeks.</brief_summary>
	<brief_title>A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Simvastatin for at Least 4 Weeks.</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Males or females &gt; or = to 18 years of age On a stable dose of simvastatin for 4 or more weeks LDLC &gt; or = to 115 mg/dL and &lt; or = to 250 mg/dL TG &lt; 300 mg/dL Women are not pregnant or breastfeeding or planning to become pregnant Women had a hysterectomy or tubal ligation or are post menopausal or are practicing an acceptable method of contraception BMI &gt; 40 Allergic to colesevelam HCl History of swallowing disorder History of gastrointestinal motility disorder Any disorder that might interfere with the study History of drug or alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>